AstraZeneca PLC Share Price Berne S.E.
Stocks
000982352
GB0009895292
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Berne S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 135.88 CHF | -2.33% |
|
-1.13% | -6.19% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 253B 223B 211B 190B 359B 24,245B 364B 2,524B 971B 12,395B 950B 929B 39,738B | P/E 2026 * |
20.8x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 273B 240B 227B 205B 387B 26,134B 392B 2,721B 1,047B 13,360B 1,023B 1,001B 42,833B | EV / Sales 2026 * |
4.31x | EV / Sales 2027 * | 3.95x |
| Free-Float |
96.62% | Yield 2026 * |
2.05% | Yield 2027 * | 2.17% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | -2.33% | ||
| 1 week | -1.13% | ||
| 1 month | +2.39% | ||
| 3 months | -9.80% | ||
| 6 months | -11.98% | ||
| Current year | -6.19% |
| 1 week | 135.71 |  | 139.89 |
| 1 month | 128.61 | | 139.89 |
| Current year | 124.91 | | 163 |
| 1 year | 124.91 | | 163 |
| 3 years | 104.86 | | 163 |
| 5 years | 95 | | 163 |
| 10 years | 52.7 | | 163 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 30/09/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 31/07/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 05/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 30/09/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 26/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -1.13% | - | - | 253B | |
| -0.78% | -2.61% | +39.45% | +113.83% | 1,031B | |
| -1.06% | -3.32% | +40.65% | +68.66% | 638B | |
| -0.54% | -1.74% | +6.60% | +75.72% | 462B | |
| -0.50% | -2.11% | +60.72% | +41.26% | 359B | |
| -0.03% | -3.96% | +23.63% | +40.70% | 335B | |
| -1.58% | -0.76% | +13.50% | +26.44% | 273B | |
| -2.02% | -2.79% | -3.07% | +10.08% | 253B | |
| -1.99% | +1.86% | +38.56% | +55.31% | 228B | |
| -0.76% | -1.09% | +33.21% | +99.82% | 185B | |
| Average | -1.17% | -0.36% | +28.14% | +59.09% | 418.21B | |
| Weighted average by Cap. | -1.02% | -0.35% | +31.14% | +70.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.17B 55.63B 52.71B 47.58B 89.68B 6,057B 90.84B 631B 243B 3,097B 237B 232B 9,928B | 67.01B 59.01B 55.91B 50.47B 95.13B 6,425B 96.36B 669B 257B 3,285B 252B 246B 10,530B |
| Net income | 12.04B 10.61B 10.05B 9.07B 17.1B 1,155B 17.32B 120B 46.27B 590B 45.22B 44.24B 1,893B | 13.77B 12.13B 11.49B 10.37B 19.55B 1,321B 19.81B 137B 52.91B 675B 51.72B 50.59B 2,164B |
| Net Debt | 19.69B 17.34B 16.43B 14.83B 27.96B 1,888B 28.32B 197B 75.66B 965B 73.95B 72.34B 3,095B | 11.93B 10.51B 9.95B 8.99B 16.94B 1,144B 17.16B 119B 45.83B 585B 44.8B 43.82B 1,875B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CHF 135.88 | -2.33% | 97 |
| 29/09/26 | CHF 139.13 | -0.05% | 20 |
| 28/09/26 | CHF 139.20 | +0.40% | 6 |
| 25/09/26 | CHF 138.63 | +1.04% | 7 |
| 24/09/26 | CHF 137.21 | -0.17% | 48 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
Select your edition
All financial news and data tailored to specific country editions
